These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1285 related items for PubMed ID: 16034009

  • 1. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.
    Wanner C, Krane V, März W, Olschewski M, Mann JF, Ruf G, Ritz E, German Diabetes and Dialysis Study Investigators.
    N Engl J Med; 2005 Jul 21; 353(3):238-48. PubMed ID: 16034009
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN).
    Knopp RH, d'Emden M, Smilde JG, Pocock SJ.
    Diabetes Care; 2006 Jul 21; 29(7):1478-85. PubMed ID: 16801565
    [Abstract] [Full Text] [Related]

  • 4. Association of LDL cholesterol and inflammation with cardiovascular events and mortality in hemodialysis patients with type 2 diabetes mellitus.
    Krane V, Winkler K, Drechsler C, Lilienthal J, März W, Wanner C, German Diabetes and Dialysis Study Investigators.
    Am J Kidney Dis; 2009 Nov 21; 54(5):902-11. PubMed ID: 19781835
    [Abstract] [Full Text] [Related]

  • 5. Effect of lowering LDL cholesterol substantially below currently recommended levels in patients with coronary heart disease and diabetes: the Treating to New Targets (TNT) study.
    Shepherd J, Barter P, Carmena R, Deedwania P, Fruchart JC, Haffner S, Hsia J, Breazna A, LaRosa J, Grundy S, Waters D.
    Diabetes Care; 2006 Jun 21; 29(6):1220-6. PubMed ID: 16731999
    [Abstract] [Full Text] [Related]

  • 6. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type 2 diabetes mellitus: adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model.
    Shinozaki T, Matsuyama Y, Iimuro S, Umegaki H, Sakurai T, Araki A, Ohashi Y, Ito H, Japanese Elderly Diabetes Intervention Trial Research Group.
    Geriatr Gerontol Int; 2012 Apr 21; 12 Suppl 1():88-102. PubMed ID: 22435944
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of Atorvastatin-induced very low-density lipoprotein cholesterol levels in Patients with coronary heart disease (a post hoc analysis of the treating to new targets [TNT] study).
    LaRosa JC, Grundy SM, Kastelein JJ, Kostis JB, Greten H, Treating to New Targets (TNT) Steering Committee and Investigators.
    Am J Cardiol; 2007 Sep 01; 100(5):747-52. PubMed ID: 17719314
    [Abstract] [Full Text] [Related]

  • 8. A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.
    Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE.
    N Engl J Med; 2005 Mar 31; 352(13):1293-304. PubMed ID: 15753114
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antihypertensive therapy and the benefits of atorvastatin in the Anglo-Scandinavian Cardiac Outcomes Trial: lipid-lowering arm extension.
    Sever PS, Poulter NR, Dahlof B, Wedel H, ASCOT Investigators.
    J Hypertens; 2009 May 31; 27(5):947-54. PubMed ID: 19318984
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial.
    Durazzo AE, Machado FS, Ikeoka DT, De Bernoche C, Monachini MC, Puech-Leão P, Caramelli B.
    J Vasc Surg; 2004 May 31; 39(5):967-75; discussion 975-6. PubMed ID: 15111846
    [Abstract] [Full Text] [Related]

  • 16. Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
    Cannon CP, Braunwald E, McCabe CH, Rader DJ, Rouleau JL, Belder R, Joyal SV, Hill KA, Pfeffer MA, Skene AM, Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators.
    N Engl J Med; 2004 Apr 08; 350(15):1495-504. PubMed ID: 15007110
    [Abstract] [Full Text] [Related]

  • 17. Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study): demographic and baseline characteristics.
    Wanner C, Krane V, März W, Olschewski M, Asmus HG, Krämer W, Kühn KW, Kütemeyer H, Mann JF, Ruf G, Ritz E, Deutsche Diabetes-Dialyse-Studie (4D) Study Group.
    Kidney Blood Press Res; 2004 Apr 08; 27(4):259-66. PubMed ID: 15316128
    [Abstract] [Full Text] [Related]

  • 18. Beneficial effects of aggressive low-density lipoprotein cholesterol lowering in women with stable coronary heart disease in the Treating to New Targets (TNT) study.
    Wenger NK, Lewis SJ, Welty FK, Herrington DM, Bittner V, TNT Steering Committee and Investigators.
    Heart; 2008 Apr 08; 94(4):434-9. PubMed ID: 18070940
    [Abstract] [Full Text] [Related]

  • 19. Focused atorvastatin therapy in managed-care patients with coronary heart disease and CKD.
    Koren MJ, Davidson MH, Wilson DJ, Fayyad RS, Zuckerman A, Reed DP, ALLIANCE Investigators.
    Am J Kidney Dis; 2009 May 08; 53(5):741-50. PubMed ID: 19216014
    [Abstract] [Full Text] [Related]

  • 20. High-dose atorvastatin after stroke or transient ischemic attack.
    Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, Hennerici M, Rudolph AE, Sillesen H, Simunovic L, Szarek M, Welch KM, Zivin JA, Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators.
    N Engl J Med; 2006 Aug 10; 355(6):549-59. PubMed ID: 16899775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.